• The coordinator of the project is Michael Merz from Novartis. The scientific coordinator is Ina Schuppe-Koistinen from Astra Zeneca.
    Managing Entity of IMI beneficiaries is NMI, represented by Nicole Schneiderhan-Marra.
    Project Management Bureau is based in Interface Europe who is responsible for the administrative and operational management of the project.
  • Please contact us by submitting your questions and comments by the Contact Form.

Contact form